Search

Author/Creator Ignatenko, S

1. P805 Selnoflast, a potent NLRP3 inhibitor - results from a phase 1b experimental medicine study in patients with Ulcerative Colitis. (30th January 2023)

Authors:
Klughammer, B; Piali, L; Nica, A C; Nagel, S; Bailey, L; Jochum, C; Ignatenko, S; Bläuer, A; Danilin, S; Gulati, P; Hayward, J; Scepanovic, P; Retout, S; Zhang, J D; Bhosale, S; Sue-Ling, K; Chong, C F; Christ, A
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i938
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus. (February 2018)

Authors:
Lu, P; Fleischmann, R; Curtis, C; Ignatenko, S; Clarke, S H; Desai, M; Wong, S L; Grebe, K M; Black, K; Zeng, J; Stolzenbach, J; Medema, J K
Journal:
Lupus
Issue:
Volume 27:Number 2(2018)
Page Start:
290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search